Company / Operating Income per Share
Zentalis Pharmaceuticals, Inc. Operating Income per Share History
FY2024-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$4.20
FY2025
5-year range
-$4.20 / -$3.21
FY2024-FY2025
Trend
-30.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
-4.20 in FY2025.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income per share decreased 30.8% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.43 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$4.20 | -30.8% |
| FY2024 | -$3.21 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026